The active role of the transcription factor Sp1 in NFATc2-mediated gene regulation in pancreatic cancer

被引:21
作者
Malsy, Manuela [1 ]
Graf, Bernhard [1 ]
Almstedt, Katrin [2 ]
机构
[1] Univ Med Ctr, Dept Anesthesiol, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany
[2] Univ Hosp, Dept Obstet & Gynecol, Mainz, Germany
来源
BMC BIOCHEMISTRY | 2019年 / 20卷
关键词
Sp1; NFATc2; Pancreatic cancer; Binding partner; Cancer; C-terminus; N-terminus; Proliferation; TUMOR-NECROSIS-FACTOR; C-FOS; MOLECULAR-BIOLOGY; TOLFENAMIC ACID; FACTOR FAMILY; GROWTH; NFAT; EXPRESSION; OVEREXPRESSION; PROGRESSION;
D O I
10.1186/s12858-019-0105-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BackgroundAdenocarcinoma of the pancreas is one of the most aggressive tumor diseases affecting the human body. The oncogenic potential of pancreatic cancer is mainly characterized by extremely rapid growth triggered by the activation of oncogenic signaling cascades, which suggests a change in the regulation of important transcription factors. Amongst others, NFAT transcription factors are assumed to play a central role in the carcinogenesis of pancreatic cancer. Recent research has shown the importance of the transcription factor Sp1 in the transcriptional activity of NFATc2 in pancreatic cancer. However, the role of the interaction between these two binding partners remains unclear. The current study investigated the role of Sp1 proteins in the expression of NFATc2 target genes and identified new target genes and their function in cells. A further objective was the domain of the Sp1 protein that mediates interaction with NFATc2.The involvement of Sp1 proteins in NFATc2 target genes was shown by means of a gene expression profile analysis, and the results were confirmed by quantitative RT-PCR. The functional impact of this interaction was shown in a thymidine incorporation assay. A second objective was the physical interaction between NFATc2 and different Sp1 deletion mutants that was investigated by means of immunoprecipitation.ResultsIn pancreatic cancer, the proto-oncogene c-Fos, the tumor necrosis factor TNF-alpha, and the adhesion molecule integrin beta-3 are target genes of the interaction between Sp1 and NFATc2. Loss of just one transcription factor inhibits oncogenic complex formation and expression of cell cycle-regulating genes, thus verifiably decreasing the carcinogenic effect. The current study also showed the interaction between the transcription factor NFATc2 and the N-terminal domain of Sp1 in pancreatic cancer cells. Sp1 increases the activity of NFATc2 in the NFAT-responsive promoter.ConclusionsThe regulation of gene promotors during transcription is a rather complex process because of the involvement of many proteins that - as transcription factors or co-factors - regulate promotor activity as required and control cell function. NFATc2 and Sp1 seem to play a key role in the progression of pancreatic cancer.
引用
收藏
页数:11
相关论文
共 49 条
  • [1] Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation
    Abdelrahim, Maen
    Baker, Cheryl H.
    Abbruzzese, James L.
    Safe, Stephen
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (12) : 855 - 868
  • [2] Interaction of tumour cells with their microenvironment: ion channels and cell adhesion molecules. A focus on pancreatic cancer
    Arcangeli, Annarosa
    Crociani, Olivia
    Bencini, Lapo
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2014, 369 (1638)
  • [3] Sp1 and the 'hallmarks of cancer'
    Beishline, Kate
    Azizkhan-Clifford, Jane
    [J]. FEBS JOURNAL, 2015, 282 (02) : 224 - 258
  • [4] The Dual Role of Tumor Necrosis Factor (TNF) in Cancer Biology
    Bertazza, L.
    Mocellin, S.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2010, 17 (29) : 3337 - 3352
  • [5] Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer
    Black, AR
    Black, JD
    Azizkhan-Clifford, J
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2001, 188 (02) : 143 - 160
  • [6] Regulation of the activity of Sp1-related transcription factors
    Bouwman, P
    Philipsen, S
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 195 (1-2) : 27 - 38
  • [7] Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway
    Buchholz, Malte
    Schatz, Alexandra
    Wagner, Martin
    Michl, Patrick
    Linhart, Thomas
    Adler, Guido
    Gress, Thomas M.
    Ellenrieder, Volker
    [J]. EMBO JOURNAL, 2006, 25 (15) : 3714 - 3724
  • [8] Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis
    Egberts, Jan-Hendrik
    Cloosters, Vera
    Noack, Andreas
    Schniewind, Bodo
    Thon, Lutz
    Klose, Stefanie
    Kettler, Bastian
    von Forstner, Corinna
    Kneitz, Christian
    Tepel, Juergen
    Adam, Dieter
    Wajant, Harald
    Kalthoff, Holger
    Trauzold, Anna
    [J]. CANCER RESEARCH, 2008, 68 (05) : 1443 - 1450
  • [9] Finkel M P, 1976, Recent Results Cancer Res, P92
  • [10] Carcinogenesis of Pancreatic Adenocarcinoma: Precursor Lesions
    Gnoni, Antonio
    Licchetta, Antonella
    Scarpa, Aldo
    Azzariti, Amalia
    Brunetti, Anna Elisabetta
    Simone, Gianni
    Nardulli, Patrizia
    Santini, Daniele
    Aieta, Michele
    Delcuratolo, Sabina
    Silvestris, Nicola
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (10): : 19731 - 19762